H. Uri Saragovi
Corporate Officer/Principal bei National Cancer Institute
Aktive Positionen von H. Uri Saragovi
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - | - |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - | - |
Karriereverlauf von H. Uri Saragovi
Ehemalige bekannte Positionen von H. Uri Saragovi
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Realist Pharma, Inc.
Realist Pharma, Inc. Pharmaceuticals: MajorHealth Technology Realist Pharma, Inc. manufactures pharmaceutical products. It is in an immuno-oncology company delivering breakthrough cancer treatments. The company was founded by Mark de Groot and H. Uri Saragovi in 2015 and is headquartered in Toronto, Canada. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2015 | - |
Gründer | 01.01.2015 | - | |
QC3 | Corporate Officer/Principal | - | - |
Bloomfield Center Alliance, Inc. | Corporate Officer/Principal | - | - |
Mortimer B. Davis Jewish General Hospital Foundation | Corporate Officer/Principal | - | - |
McGill University | Corporate Officer/Principal | - | - |
Mimetogen Pharmaceuticals, Inc.
Mimetogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Mimetogen Pharmaceuticals, Inc. develops peptidomimetic small molecule drugs against glaucoma and cancer. Its product mimic the effects of neurotrophin proteins that help to maintain the health and growth of cells and tissues found in the eye. Mimetogen provides tyrosine kinase agonists that prevent neuronal death; small molecule tyrosine kinase receptor agonists, which stimulates mucin secretion from conunctival goblet cells; and small molecule neurotrophin mimetics that rescues retinal pigment epithelial cells from oxidative stress-induced apoptosis. The company was founded by Garth Cumberlidge and H. Uri Saragovi in 2005 and is headquartered in Montreal, Canada. | Direktor/Vorstandsmitglied | 01.12.2004 | - |
Technik-/Wissenschafts-/F&E-Leiter | 01.12.2004 | 26.05.2010 | |
Gründer | 12.10.2009 | - |
Ausbildung von H. Uri Saragovi
Brandeis University | Undergraduate Degree |
University of Miami | Doctorate Degree |
Statistik
International
Kanada | 6 |
Vereinigte Staaten | 6 |
Operativ
Corporate Officer/Principal | 6 |
Chief Tech/Sci/R&D Officer | 2 |
Founder | 2 |
Sektoral
Consumer Services | 4 |
Health Technology | 3 |
Miscellaneous | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 7 |
---|---|
Mimetogen Pharmaceuticals, Inc.
Mimetogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Mimetogen Pharmaceuticals, Inc. develops peptidomimetic small molecule drugs against glaucoma and cancer. Its product mimic the effects of neurotrophin proteins that help to maintain the health and growth of cells and tissues found in the eye. Mimetogen provides tyrosine kinase agonists that prevent neuronal death; small molecule tyrosine kinase receptor agonists, which stimulates mucin secretion from conunctival goblet cells; and small molecule neurotrophin mimetics that rescues retinal pigment epithelial cells from oxidative stress-induced apoptosis. The company was founded by Garth Cumberlidge and H. Uri Saragovi in 2005 and is headquartered in Montreal, Canada. | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
Mortimer B. Davis Jewish General Hospital Foundation | |
Bloomfield Center Alliance, Inc. | |
QC3 | |
Realist Pharma, Inc.
Realist Pharma, Inc. Pharmaceuticals: MajorHealth Technology Realist Pharma, Inc. manufactures pharmaceutical products. It is in an immuno-oncology company delivering breakthrough cancer treatments. The company was founded by Mark de Groot and H. Uri Saragovi in 2015 and is headquartered in Toronto, Canada. | Health Technology |
- Börse
- Insiders
- H. Uri Saragovi
- Erfahrung